INTRODUCTION
1.2 MARKET DEFINITION
• Human insulin is the class of biosynthetic product that is manufactured from bacteria ( such as Escherichia coli ) by recombinant DNA technology . The synthetic insulin prepared by rDNA method is either structurally same ( human insulin biologics ) or similar ( human insulin biosimilars ) as that of naturally occurring insulin in humans .
• Furthermore , human insulin products covered under the study scope of the human insulin market includes human insulin drugs ( biologics & biosimilars , including generic drugs ) as well as delivery devices that are used for human insulin administration . However , human insulin market scope includes syringes , pens , and pen needles , and does not cover other human insulin delivery devices such as human insulin pumps , patches , and inhalation devices .
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
• This research report categorizes the global human insulin market into the following segments :
•
�
•
•
�
•
•
•
•
�
•
•
•
•
�
•
•
•
�
�
�
�
�
•
•
•
�
•
•
•
�
�
•
•
�
•
•
�
•
•
•
�
•
•
•
•
•
• sales @ marketsandmarkets . com www . marketsandmarkets . com
2